Microincisional Cataract Surgery: Harmony Ensures Success

Using the latest phaco technologies will help improve safety and efficacy
Today’s phacoemulsification systems have made sub- 3.0mm incisions standard. Better fluidics control during smaller-incision surgery means we also have fewer collapsing chambers and fewer intraoperative problems. This is the main reason I use microincisional surgical techniques today. But it’s by far not the only one.
[caption id='attachment_57' align='alignnone' width='575' caption='A Tecnis 1-piece IOL is implanted via a 2.2mm incision using a new micro-implantation suite that harmonises the latest phaco and lens technology with a small-incision injector system']
Another reason to consider microincisional surgery is because it helps minimise induced astigmatism, a critical factor in an age when patients are demanding true emmetropia, not just the spherical equivalent. Consider that a good majority of patients present with 0.5 D - 1.0 D of astigmatism. Cataract surgery, with some degree of induced cylinder, may result in a final astigmatism of 1.5 D or even 2.0 D. That’s not good enough.
Surgeons with a burgeoning presbyopia patient base must consistently achieve emmetropia. For our most demanding patients – those who want both their presbyopia and astigmatism corrected – we need to minimise the amount of induced astigmatism. With clear corneal incisions approaching 2.0mm or less, surgeons can reduce the amount of induced astigmatism to about 0.25 D. I believe patient demands will continue to drive our techniques to smaller and smaller incisions.
But none of that will matter unless there is complete harmony between the machine and the type of surgery one performs. For me, it is crucial that all the components of cataract surgery – the handpiece, phacoemulsification system, lens injector and IOL – work together, regardless of incision size.
For example, it makes little sense to perform surgery through a small incision only to enlarge the wound to insert a particular lens. Similarly, if surgeons try to squeeze a 2.2mm injector through a 2.0mm incision, they will either damage the wound construction or get a fishmouth configuration where the wound doesn’t close properly. This is problematic, because when the surgeon hydrates the paracentesis, the fluid just leaks out. This will result in a necessary suture and the astigmatic calculation will be off. In the end, I prefer enlarging the wound slightly over forcing an injector through.
System dynamics
Hydrophilic IOLs (in Germany, most are from Acri.Tec and Zeiss) can be rolled and implanted through the smallest, 1.8mm or 1.5mm incisions. In Germany, the two companies with the greatest market share in both phaco systems and IOLs (Abbott Medical Optics and Alcon) both have systems where the phaco handpieces can go through a 2.0mm incision, through which one can then implant hydrophobic IOLs. AMO’s new Micro- Implantation Cataract Suite includes an injector that is compatible with all dioptre versions of the Tecnis IOL (including the multifocal and toric). An added advantage for the surgical staff is that there is only one cartridge size, which makes IOL preparation much easier.
The smaller the incision, the more careful the surgeon must be in removing viscoelastic. Viscoelastics are easily flushed out of a 4.0mm incision, but with a tight, small incision, every little molecule must be removed by irrigation and aspiration (I/A). Especially in cases where Healon 5 or DuoVisc are used, one should be very thorough in removing it.
In my opinion, there are two factors that will help make microincisional cataract surgery successful. The first is creating small incisions, with careful attention to wound architecture in order to minimise induced astigmatism; the second, the ability to use modern lenses and the most updated phaco systems in conjunction with those small incisions.
Prof Auffarth is professor and chairman of the Department of Ophthalmology at the University of Heidelberg in Germany. He receives research support from AMO, Carl Zeiss Meditec, Rayner and Schwind Eye- Tech Solutions. Contact him at: Gerd.Auffarth@med. uni-heidelberg.de.Â
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.